Abiopharma

🔍 Vattuone Steven (Executive)

Company: ON24 INC. (ONTF)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 79,935 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: false | shares_owned_after: 511,936.00 | transaction_form_type: 4
• Sold 511,936 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: D | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
• Sold 90,982 shares of Stock Options (Right to buy) at $13.33 per share (Derivative)
  Date: 2026-04-01 | Code: D | Expires: 2030-12-11 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2
• Sold 9,018 shares of Stock Options (Right to buy) at $13.33 per share (Derivative)
  Date: 2026-04-01 | Code: D | Expires: 2030-12-11 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Pursuant to the Agreement and Plan of Merger, dated as of December 29, 2025 (the "Merger Agreement") among the Issuer, Cvent Atlanta, LLC ("Parent"), and Summit Sub Corp. ("Merger Sub"), on April 1, 2026, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving company and a wholly-owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each outstanding share of Issuer common stock was automatically canceled and converted into the right to receive cash in an amount equal to $8.10 per share, without interest, with similar treatment for outstanding RSUs except that unvested RSUs remain subject to time-based vesting conditions.
• F2: At the effective time of the Merger, each outstanding option to purchase Issuer common stock was automatically canceled and converted into the right to receive cash in an amount equal to $8.10 less the exercise price per share of such option.